2002
DOI: 10.1001/archderm.138.6.740
|View full text |Cite
|
Sign up to set email alerts
|

Denileukin Diftitox for the Treatment of Panniculitic Lymphoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 16 publications
1
13
0
Order By: Relevance
“…Case reports describe durable responses with denileukin diftitox in cases of SPTL-AB. 19,20,21 Interferon-α is also reported to be active in refractory SPTL-AB. 18 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Case reports describe durable responses with denileukin diftitox in cases of SPTL-AB. 19,20,21 Interferon-α is also reported to be active in refractory SPTL-AB. 18 …”
Section: Introductionmentioning
confidence: 99%
“…21 In this retrospective review, we report our experience treating 15 patients, including 3 children, with SPTL-AB and CGD-TCL with bexarotene.…”
Section: Introductionmentioning
confidence: 99%
“…3 In addition, denileukin diftitox, a recombinant fusion protein of human interleukin-2 and diphtheria toxin, has recently been used successfully. 20 The course and pattern of disease progression in this case raises the question as to whether an earlier diagnosis may have changed our patient's outcome. However, the high rate of mortality described in SPTCL is well established to be secondary to the HPS accompanying the disorder in most cases, rather than dissemination of the lymphoma itself.…”
Section: Discussionmentioning
confidence: 87%
“…Clinical regression of disease with corticosteroids and denileukin diftitox was seen in two cases with median duration of response for 6 months and more than 18 months. Furthermore, the addition of bexarotene to denileukin diftitox restored a clinical response in 1 of the patients after disease [64]. Interferon alpha is also reported to be active in refractory SPTCL [10].…”
Section: Discussionmentioning
confidence: 97%